Keith Black, MD & The First Eye Test for Alzheimer's | Cedars-Sinai

More than 5 million Americans have Alzheimer’s disease. That number will triple by 2050, according to the Alzheimer’s Association. A non-invasive eye scan being studied by Cedars-Sinai neuroscience researchers could help identify people at high risk for Alzheimer’s disease years before they experience symptoms, according to a study published in the Journal of Clinical Investigation. The hope is that eventually the scan will be used as a screening device to detect the disease early enough to intervene and change its course, says Dr. Keith L. Black, chair of the Department of Neurosurgery at Cedars-Sinai. In this video, Dr. Black and his team talk about using retinal scans to detect Alzheimer’s and how to prevent the disease.

Connect with us:
https://twitter.com/CedarsSinai
https://www.facebook.com/CedarsSinai
https://instagram.com/CedarsSinai


################################################

Cedars-Sinai is a leader in providing high-quality healthcare encompassing primary care, specialized medicine and research. Since 1902, Cedars-Sinai has evolved to meet the needs of one of the most diverse regions in the nation, setting standards in quality and innovative patient care, research, teaching and community service. Today, Cedars- Sinai is known for its national leadership in transforming healthcare for the benefit of patients. Cedars-Sinai impacts the future of healthcare by developing new approaches to treatment and educating tomorrow’s health professionals. Additionally, Cedars-Sinai demonstrates a commitment to the community through programs that improve the health of its most vulnerable residents.